Tilray CEO On Future Of Cannabis And Federal Rescheduling: ‘We Did Not Sit Back And Wait’
The rescheduling of cannabis from a Schedule I to a Schedule III substance is on the horizon. Whether it happens before or after the upcoming election doesn’t not worry Tilray’s (NASDAQ:TLRY) CEO Irwin Simon. He says he’s confident about the future of the company regardless.
“We did not sit back and wait”, he said in an interview with the show Wealth! in Yahoo Finance where he went though the company’s latest earnings report.
Economic Trends
“We now have a strong beer business, a spirits business”, referring to the beverages strategy that helped the company build a craft beer division that has already landed interesting economic results. Tilray has also recently won a spirits competition, which is helping …